J Korean Med Assoc.  2013 Jul;56(7):560-561. 10.5124/jkma.2013.56.7.560.

Current status and future in patients with end stage renal disease in Korea

Affiliations
  • 1Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicne, Seoul, Korea. yangch@catholic.ac.kr

Abstract

No abstract available.


MeSH Terms

Humans
Kidney Failure, Chronic
Korea

Cited by  2 articles

Factors related to Family Support for Hemodialysis Patients: A Systematic Review and Meta-analysis
Young Ran Chae, Sun Hee Lee, Young Mi Jo, Hyo Young Kang
Korean J Adult Nurs. 2019;31(2):123-135.    doi: 10.7475/kjan.2019.31.2.123.

Quality of Life among End-stage Renal Disease Treatments and Economic Evaluation of Renal Transplantation and Hemodialysis Treatments
Kyung-Ock Jeon, Sun-Young Son, Myung-Il Hahm, Soon-Il Kim
J Korean Soc Transplant. 2015;29(4):200-208.    doi: 10.4285/jkstn.2015.29.4.200.


Reference

1. Jin DC. Current status of dialysis therapy in Korea. Korean J Intern Med. 2011; 26:123–131.
Article
2. Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011; 18:428–432.
Article
3. Wang AY. Clinical utility of natriuretic peptides in dialysis patients. Semin Dial. 2012; 25:326–333.
Article
4. Butman M, Nissenson AR. Dialysis outcomes as a measure of adequacy of dialysis. Semin Nephrol. 2005; 25:70–75.
Article
5. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004; 80:299–307.
Article
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr